BACKGROUND: Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral weight-loss intervention in adults with serious mental illness. METHODS: We recruited overweight or obese adults from 10 community psychiatric rehabilitation outpatient programs and randomly assigned them to an intervention or a control group. Participants in the intervention group received tailored group and individual weight-management sessions and group exercise sessions. Weight change was assessed at 6, 12, and 18 months. RESULTS: Of 291 participants who underwent randomization, 58.1% had schizophrenia or a schizoaffective disorder, 22.0% had bipolar disorder, and 12.0% had major depression. At baseline, the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 36.3, and the mean weight was 102.7 kg (225.9 lb). Data on weight at 18 months were obtained from 279 participants. Weight loss in the intervention group increased progressively over the 18-month study period and differed significantly from the control group at each follow-up visit. At 18 months, the mean between-group difference in weight (change in intervention group minus change in control group) was -3.2 kg (-7.0 lb, P=0.002); 37.8% of the participants in the intervention group lost 5% or more of their initial weight, as compared with 22.7% of those in the control group (P=0.009). There were no significant between-group differences in adverse events. CONCLUSIONS: A behavioral weight-loss intervention significantly reduced weight over a period of 18 months in overweight and obese adults with serious mental illness. Given the epidemic of obesity and weight-related disease among persons with serious mental illness, our findings support implementation of targeted behavioral weight-loss interventions in this high-risk population. (Funded by the National Institute of Mental Health; ACHIEVE ClinicalTrials.gov number, NCT00902694.).
RCT Entities:
BACKGROUND: Overweight and obesity are epidemic among persons with serious mental illness, yet weight-loss trials systematically exclude this vulnerable population. Lifestyle interventions require adaptation in this group because psychiatric symptoms and cognitive impairment are highly prevalent. Our objective was to determine the effectiveness of an 18-month tailored behavioral weight-loss intervention in adults with serious mental illness. METHODS: We recruited overweight or obese adults from 10 community psychiatric rehabilitation outpatient programs and randomly assigned them to an intervention or a control group. Participants in the intervention group received tailored group and individual weight-management sessions and group exercise sessions. Weight change was assessed at 6, 12, and 18 months. RESULTS: Of 291 participants who underwent randomization, 58.1% had schizophrenia or a schizoaffective disorder, 22.0% had bipolar disorder, and 12.0% had major depression. At baseline, the mean body-mass index (the weight in kilograms divided by the square of the height in meters) was 36.3, and the mean weight was 102.7 kg (225.9 lb). Data on weight at 18 months were obtained from 279 participants. Weight loss in the intervention group increased progressively over the 18-month study period and differed significantly from the control group at each follow-up visit. At 18 months, the mean between-group difference in weight (change in intervention group minus change in control group) was -3.2 kg (-7.0 lb, P=0.002); 37.8% of the participants in the intervention group lost 5% or more of their initial weight, as compared with 22.7% of those in the control group (P=0.009). There were no significant between-group differences in adverse events. CONCLUSIONS: A behavioral weight-loss intervention significantly reduced weight over a period of 18 months in overweight and obese adults with serious mental illness. Given the epidemic of obesity and weight-related disease among persons with serious mental illness, our findings support implementation of targeted behavioral weight-loss interventions in this high-risk population. (Funded by the National Institute of Mental Health; ACHIEVE ClinicalTrials.gov number, NCT00902694.).
Authors: Gary D Foster; Holly R Wyatt; James O Hill; Angela P Makris; Diane L Rosenbaum; Carrie Brill; Richard I Stein; B Selma Mohammed; Bernard Miller; Daniel J Rader; Babette Zemel; Thomas A Wadden; Thomas Tenhave; Craig W Newcomb; Samuel Klein Journal: Ann Intern Med Date: 2010-08-03 Impact factor: 25.391
Authors: Gail L Daumit; Christopher B Anthony; Daniel E Ford; Maureen Fahey; Elizabeth Ann Skinner; Anthony F Lehman; Wenke Hwang; Donald M Steinwachs Journal: Psychiatry Res Date: 2010-03-05 Impact factor: 3.222
Authors: David B Allison; John W Newcomer; Andrea L Dunn; James A Blumenthal; Anthony N Fabricatore; Gail L Daumit; Mark B Cope; William T Riley; Betty Vreeland; Joseph R Hibbeln; Jonathan E Alpert Journal: Am J Prev Med Date: 2009-04 Impact factor: 5.043
Authors: Jack F Hollis; Christina M Gullion; Victor J Stevens; Phillip J Brantley; Lawrence J Appel; Jamy D Ard; Catherine M Champagne; Arlene Dalcin; Thomas P Erlinger; Kristine Funk; Daniel Laferriere; Pao-Hwa Lin; Catherine M Loria; Carmen Samuel-Hodge; William M Vollmer; Laura P Svetkey Journal: Am J Prev Med Date: 2008-08 Impact factor: 5.043
Authors: Frank M Sacks; George A Bray; Vincent J Carey; Steven R Smith; Donna H Ryan; Stephen D Anton; Katherine McManus; Catherine M Champagne; Louise M Bishop; Nancy Laranjo; Meryl S Leboff; Jennifer C Rood; Lilian de Jonge; Frank L Greenway; Catherine M Loria; Eva Obarzanek; Donald A Williamson Journal: N Engl J Med Date: 2009-02-26 Impact factor: 91.245
Authors: Sarah S Casagrande; Gerald J Jerome; Arlene T Dalcin; Faith B Dickerson; Cheryl A Anderson; Lawrence J Appel; Jeanne Charleston; Rosa M Crum; Deborah R Young; Eliseo Guallar; Kevin D Frick; Richard W Goldberg; Meghan Oefinger; Joseph Finkelstein; Joseph V Gennusa; Oladapo Fred-Omojole; Leslie M Campbell; Nae-Yuh Wang; Gail L Daumit Journal: BMC Psychiatry Date: 2010-12-13 Impact factor: 3.630
Authors: Christina Mangurian; Aishat Giwa; Erin Brosey; Martha Shumway; James Dilley; Elena Fuentes-Afflick; Eliseo J Pérez-Stable; Dean Schillinger Journal: J Am Board Fam Med Date: 2019 May-Jun Impact factor: 2.657
Authors: Frank Schneider; Michael Erhart; Walter Hewer; Leonie Ak Loeffler; Frank Jacobi Journal: Dtsch Arztebl Int Date: 2019-06-10 Impact factor: 5.594
Authors: John A Naslund; Kelly A Aschbrenner; Emily A Scherer; Sarah I Pratt; Rosemarie S Wolfe; Stephen J Bartels Journal: Am J Prev Med Date: 2015-09-16 Impact factor: 5.043
Authors: Judith J Prochaska; Sebastien C Fromont; Kevin Delucchi; Kelly C Young-Wolff; Neal L Benowitz; Stephen Hall; Thomas Bonas; Sharon M Hall Journal: Health Psychol Date: 2014-01-27 Impact factor: 4.267